Ossen Innovation (OSN) Reports Q3 EPS of $0.02

Ossen Innovation (NASDAQ: OSN) reported Q3 EPS of $0.02, versus $0.08 reported last year. Revenue for the quarter came in at $27.9 million, versus $33.1 million reported last year.

For earnings history and earnings-related data on Ossen Innovation (OSN) click here.

You May Also Be Interested In

• Karyopharm Therapeutics (KPTI) Misses Q2 EPS by $1.01, Beats on Revenue; Offers FY26 Revenue Guidance
• MiNK Therapeutics reports Q2 2026 results and Phase 2 trial data
• Cellectar Biosciences (CLRB) Misses Q2 EPS by 9c